HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by testing for the lowest luminance flash which elicits a visual sensation perceived by the subject. FST can quantitate vision in subjects who cannot be studied with conventional methods due to low vision, nystagmus and/or inability to fix. It can be used to monitor progression of a blinding disease, and potential therapeutic effect of a therapy. FST is being used in international studies measuring the natural course of inherited retinal dystrophies, and it is approved by FDA to monitor the therapeutic effect of Luxturna gene therapy. The configuration must includes a dark adaptometry module and a movable equipment trolley.
The procurement also includes device-specific consumables and an option right to purchase a maximum of two (2) similar device sets between 2024 and 2026. The use of options will be decided later. The agreement for device-specific consumables will be in force for a fixed period of four (4) years and thereafter until terminated.
A maintenance contract must be offered as a mandatory option. The implementation of the maintenance contract is decided separately.
The object of the procurement and the requirements pertaining to it are described in detail in the call for tenders and its attachments.
Määräaika
Tarjousten vastaanottamisen määräaika oli 2023-09-01.
Hankinta julkaistiin 2023-07-20.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
hankintailmoitus (2023-07-20) Kohde Hankinnan laajuus
Otsikko: Lääketieteelliset laitteet
Viitenumero: HUS 385-2023
Lyhyt kuvaus:
“HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by...”
Lyhyt kuvaus
HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by testing for the lowest luminance flash which elicits a visual sensation perceived by the subject. FST can quantitate vision in subjects who cannot be studied with conventional methods due to low vision, nystagmus and/or inability to fix. It can be used to monitor progression of a blinding disease, and potential therapeutic effect of a therapy. FST is being used in international studies measuring the natural course of inherited retinal dystrophies, and it is approved by FDA to monitor the therapeutic effect of Luxturna gene therapy. The configuration must includes a dark adaptometry module and a movable equipment trolley.
Näytä lisää Ilmoituksen metatiedot
Alkukieli: englanti 🗣️
Asiakirjatyyppi: hankintailmoitus
Sopimuksen luonne: Tavarat
Asetus: Euroopan unioni ja WTO-maat
Yhteinen hankintanimikkeistö (CPV)
Koodi: Lääketieteelliset laitteet📦 Suorituspaikka
NUTS-alue: Helsinki-Uusimaa🏙️
Menettely
Menettelyn tyyppi: Avoin menettely
Tarjouksen tyyppi: Tarjous koskee kaikkia eriä
Myöntämisperusteet
Kokonaistaloudellisesti edullisin tarjous
“The times given in the call for tenders are given in Finnish time. The date of the opening of tenders is a preliminary date.”
Lähde: OJS 2023/S 141-450337 (2023-07-20)
Lisätietoilmoitus (2023-08-21) Kohde Ilmoituksen metatiedot
Asiakirjatyyppi: Lisätietoilmoitus
“The deadline is extended because the Tarjouspalvelu.fi-portal will be down between 1 and 4 September 2023.”
Lähde: OJS 2023/S 163-512004 (2023-08-21)
Ilmoitus tehdystä sopimuksesta (2023-10-30) Kohde Hankinnan laajuus
Otsikko: K2513500005 ERG-device with FST
Lyhyt kuvaus:
“HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by...”
Lyhyt kuvaus
HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by testing for the lowest luminance flash which elicits a visual sensation perceived by the subject. FST can quantitate vision in subjects who cannot be studied with conventional methods due to low vision, nystagmus and/or inability to fix. It can be used to monitor progression of a blinding disease, and potential therapeutic effect of a therapy. FST is being used in international studies measuring the natural course of inherited retinal dystrophies, and it is approved by FDA to monitor the therapeutic effect of Luxturna gene therapy. The configuration must includes a dark adaptometry module and a movable equipment trolley.
The procurement also includes device-specific consumables and an option right to purchase a maximum of two (2) similar device sets between 2024 and 2026. The use of options will be decided later. The agreement for device-specific consumables will be in force for a fixed period of four (4) years and thereafter until terminated.
A maintenance contract must be offered as a mandatory option. The implementation of the maintenance contract is decided separately.
The object of the procurement and the requirements pertaining to it are described in detail in the call for tenders and its attachments.
The deadline is extended because the Tarjouspalvelu.fi-portal will be down between 1 and 4 September 2023.
Näytä lisää
Sopimustyyppi: Tavarat
Tuotteet/palvelut: Lääketieteelliset laitteet📦
Arvioitu arvo ilman arvonlisäveroa: 298 000 EUR 💰
Hankinnan kokonaisarvo (ilman arvonlisäveroa): 298 000 EUR 💰
Kuvaus
Hankinnan kuvaus:
“HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by...”
Hankinnan kuvaus
HUS aims to purchase a combined ERG- and FST device. FST (full field stimulus threshold) test is used to measure the sensitivity of the visual field by testing for the lowest luminance flash which elicits a visual sensation perceived by the subject. FST can quantitate vision in subjects who cannot be studied with conventional methods due to low vision, nystagmus and/or inability to fix. It can be used to monitor progression of a blinding disease, and potential therapeutic effect of a therapy. FST is being used in international studies measuring the natural course of inherited retinal dystrophies, and it is approved by FDA to monitor the therapeutic effect of Luxturna gene therapy. The configuration must includes a dark adaptometry module and a movable equipment trolley.
The procurement also includes device-specific consumables and an option right to purchase a maximum of two (2) similar device sets between 2024 and 2026. The use of options will be decided later. The agreement for device-specific consumables will be in force for a fixed period of four (4) years and thereafter until terminated.
A maintenance contract must be offered as a mandatory option. The implementation of the maintenance contract is decided separately.
The object of the procurement and the requirements pertaining to it are described in detail in the call for tenders and its attachments.
The deadline is extended because the Tarjouspalvelu.fi-portal will be down between 1 and 4 September 2023.
Näytä lisää Myöntämisperusteet
Hinta ✅
Hinta (painotus): 60
Laatukriteeri (painotus): 40
Otsikko
Erän tunnistenumero: LOT-0000
Menettely Toimenpiteen tyyppi
Avoin menettely ✅
Sopimuksen tekeminen
Sopimus/erä myönnetään ✅
Erän tunnistenumero: LOT-0000
Sopimuksen numero: HUS 385-2023
Otsikko: K2513500005 ERG-device with FST
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: 198 000 EUR 💰
Toimeksisaajan nimi ja osoite
Nimi: Diagnosys Vision Limited
Kansallinen rekisterinumero: IE 3596480BH
Postitoimipaikka: Dublin
Alue: Dublin 🏙️
Maa: Irlanti 🇮🇪
Sähköposti: support@diagnosysllc.com📧
Puhelin: +44 (0) 1223 520 699📞
Hankintaviranomainen Nimi ja osoitteet
Nimi: HUS Group, the joint authority for Helsinki and Uusimaa
Kansallinen rekisterinumero: 1567535-0
Postiosoite: Uutistie 3C (P.O. Box 445, 00029 HUS)
Postinumero: 01770
Postitoimipaikka: Vantaa
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Sähköposti: kilpailutus.tiimi@hus.fi📧
Puhelin: +358 94711📞
URL: http://www.hus.fi🌏 Hankintaviranomaisen tyyppi
Alue- tai paikallistason viranomainen
Päätoimi
Terveys
Täydentävät tiedot Arvostelurunko
Nimi: Markkinaoikeus
Kansallinen rekisterinumero: 3006157-6
Postiosoite: Radanrakentajantie 5
Postinumero: 00520
Postitoimipaikka: Helsinki
Alue: Helsinki-Uusimaa🏙️
Maa: Suomi 🇫🇮
Sähköposti: markkinaoikeus@oikeus.fi📧
Puhelin: +358 295643300📞
URL: http://www.oikeus.fi/markkinaoikeus🌏
Lähde: OJS 2023/S 210-665173 (2023-10-30)